1.
The role of rituximab in the treatment of ANCA-associated vasculitides (AAV). Swiss Med Wkly [Internet]. 2015 Jan. 25 [cited 2026 Jan. 8];145(0506):w14103. Available from: https://www.smw.ch/index.php/smw/article/view/1980